3655 NOBEL DRIVE, SAN DIEGO, CA
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Investor Presentation
By-Laws Amendment - Quorum Requirement Reduced for Stockholder Meetings
Announces Pricing of $6.0 Million Registered Direct Offering
Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Regulation A Offering Circular Supplement (Annual Report)
QUALIF
Offering Statement - Qualified Offering Circular
Regulation A Offering Circular Supplement